Strategic Analysis of Pharmaceutical Direct-to-Consumer Advertising in Europe


USD 3,950.00

* Required Fields

USD 3,950.00


Be the first to review this product

This Frost and Sullivan’s Strategic Analysis Service examines the status of pharmaceutical direct-to-consumer advertising in Europe. This service focuses on developments as well as provides general strategies.

Table of Contents

Strategic Analysis of Pharmaceutical Direct-to-Consumer Advertising in Europe, Strategic Analysis of Pharmaceutical Direct-to-Consumer Advertising in EuropeIntroductionIntroductionOverviewDirect-to-Consumer Advertising in EuropePharmaceutical Direct-to-Consumer Advertising in EuropeChallenges faced by DTC in EuropeKey Market DriversBenefits of DTCA to Patients and Pharmaceutical CompaniesKey RestraintsCommunication ChartDTCA and DTPA in EuropeMediaDTC Advertising MediaMedia ExpenditureCompetitive LandscapeRegional AnalysisDTCA CompaniesDirect-to-Consumer Advertising Expenditure Forecasts and AnalysisDTCA Expenditure Forecasts and AnalysisRegional AnalysisDTCA Expenditure Forecasts and Analysis for EuropeStrategic Analysis and RecommendationsStrategic Analysis and RecommendationsFrost & Sullivan AwardsFrost & Sullivan AwardsCustomer Service Leadership AwardBrand Development Strategy Leadership AwardDecision Support DatabasesDecision Support DatabasesFrost & SullivanOur TeamConsulting Capabilities

Related Research

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.